Lamivudine

Product NDC

70518-1083

11-digit product format

705181083

Labeler code

70518

Product ID

70518-1083_687ec720-1d5f-37ac-e053-2a91aa0a0aa1

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Lamivudine

Dosage form

TABLET

Route

ORAL

Labeler

REMEDYREPACK INC.

Application

ANDA206974

Marketing category

ANDA

Marketing start

2018-03-27

Marketing end

0000-00-00

Substance

LAMIVUDINE

Active strength

300 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]

NDC exclude flag

No

Listing certified through

2019-12-31

Current FDA listing

Historical FDA.report record